Palisade Bio, Inc.
PALINasdaqCIK 1357459HealthcareFiscal year ends Dec 31
Reports and events: 461 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1016:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001357459-26-000017 |
| 2026-08-1016:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001357459-26-000016 |
| 2026-06-1117:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-028322 |
| 2026-05-1216:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001357459-26-000011 |
| 2026-05-1216:04 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001357459-26-000010 |
| 2026-04-2916:49 ET | DEF 14A | Proxy statementPeriod 2026-04-29 | 0001493152-26-019629 |
| 2026-04-0208:34 ET | 8-K | 8.01 Other events | 0001493152-26-014822 |
| 2026-03-2016:22 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001357459-26-000004 |
| 2025-12-0416:40 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-026195 |
| 2025-11-1016:14 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274262 |
| 2025-10-2809:34 ET | DEF 14A | Proxy statementPeriod 2025-10-28 | 0001493152-25-019900 |
| 2025-10-2216:35 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-018922 |
| 2025-10-2017:22 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-018684 |
| 2025-10-1616:30 ET | 8-K | 8.01 Other events | 0001493152-25-018324 |
| 2025-10-0917:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-017630 |
| 2025-09-2906:43 ET | S-1 | Registration statement | 0001493152-25-015872 |
| 2025-09-2617:10 ET | 8-K | 8.01 Other events | 0001493152-25-015775 |
| 2025-09-1816:27 ET | 8-K | 8.01 Other events | 0001493152-25-014071 |
| 2025-09-1510:05 ET | DEF 14A | Proxy statementPeriod 2025-09-15 | 0001493152-25-013379 |
| 2025-09-0509:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-012687 |
| 2025-08-1816:32 ET | DEF 14A | Proxy statementPeriod 2025-08-18 | 0001641172-25-024628 |
| 2025-08-1116:26 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106587 |
| 2025-07-2519:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020896 |
| 2025-07-0908:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-018313 |
| 2025-05-2708:41 ET | S-1 | Registration statement | 0001641172-25-012405 |
| 2025-05-1216:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069204 |
| 2025-05-0216:11 ET | 8-K | 3.01 Delisting notice | 0001641172-25-008346 |
| 2025-03-2416:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-043859 |
| 2024-12-1616:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-050203 |
| 2024-12-0917:30 ET | S-1/A | Registration statement, amended | 0001493152-24-049323 |
| 2024-12-0510:25 ET | S-1/A | Registration statement, amended | 0001493152-24-048819 |
| 2024-11-2114:18 ET | S-1/A | Registration statement, amended | 0001493152-24-047112 |
| 2024-11-1208:33 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124664 |
| 2024-10-3006:05 ET | S-1 | Registration statement | 0001493152-24-042973 |
| 2024-09-2716:31 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-038547 |
| 2024-08-1216:11 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095432 |
| 2024-07-0817:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-026504 |
| 2024-05-2216:45 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0001493152-24-021034 |
| 2024-05-1316:07 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-058644 |
| 2024-05-1016:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-018687 |
| 2024-05-0316:56 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-017739 |
| 2024-04-1017:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-014253 |
| 2024-04-0516:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-013336 |
| 2024-03-2716:45 ET | 8-K | 2.02 Results of operations; 3.01 Delisting notice; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-011527 |
| 2024-03-2616:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-036402 |
| 2024-03-0616:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-009042 |
| 2024-02-1316:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-006132 |
| 2024-02-0617:00 ET | DEF 14A | Proxy statementPeriod 2024-02-06 | 0001493152-24-005117 |
| 2024-02-0106:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-004539 |
| 2024-01-2908:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-004066 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:35 ET. Listed shows no prices and gives no investment advice.